[Pharmacological correction of lipid metabolism disturbances using new amide derivatives of taurine].
Taurine derivatives taurepar, tauritman and IEM-1702 exhibit a significant hypolipidemic activity. The most pronounced effect was observed for taurepar, which effectively prevented the experimental dislipoproteinemia in albino rats and guinea pigs.
Okunevich
I V
IV
Gavrovskaia
L K
LK
Sapronov
N S
NS
D000818:Animals; D004032:Diet; D050171:Dyslipidemias / Q000188:drug therapy; D006168:Guinea Pigs; D000960:Hypolipidemic Agents / Q000627:therapeutic use*; D050356:Lipid Metabolism / Q000187:drug effects*; D008297:Male; D051381:Rats; D013045:Species Specificity; D013654:Taurine / Q000031:analogs & derivatives* / Q000627:therapeutic use
D000960:Hypolipidemic Agents; C518137:IEM-1702; C518136:taurepar; D013654:Taurine